Promimic AB develops and provides surface modification technologies for medical and dental implants, specifically utilizing its HA nano Surface to enhance hydrophilicity and accelerate bone growth. The company serves implant manufacturers in the orthopedic, dental, and biosensor sectors.
Subscribe to see Promimic AB’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Promimic AB is a medical devices company headquartered in Sweden. Xcout tracks 10 named people at Promimic AB, including Jeffrey Cotten (President, Chief Executive Officer & Director).
4 more named people on record for Promimic AB, with roles, board committees and tenure — see the full roster →
A few of Promimic AB's closest competitors — see the full list of competitors and alternatives →
OssDsign AB develops and globally provides orthobiologics products based on material science to support the body's healing capabilities. The company specifically markets products such as OssDsign Catalyst, a nanosynthetic bone graft designed for spine surgery and bone fusion procedures, serving surgeons and patients.
Osstell is a dental technology company headquartered in Gothenburg, Sweden. The company specializes in product solutions for dental implants and provides diagnostic tools used in more than 70 countries.
Heraeus Medical develops and manufactures medical solutions for surgical orthopaedics and trauma surgery, including bone cements for implant fixation, products for musculoskeletal infection management, and resorbable biomaterials for bone regeneration. The company serves healthcare professionals and patients globally by providing products designed to restore patient mobility.
Moximed, Inc. is a medical device company headquartered in Hayward, California. The company focuses on developing motion-preservation joint implants and orthopedic solutions designed to treat osteoarthritis.
aap Implantate AG develops and manufactures trauma surgery products, focusing on medical implants, bone plates, and screws for extremities. The company utilizes its proprietary LOQTEQ technology to provide locking compression systems and bone substitutes for hospitals, surgeons, and patients.
BioSurfaces, LLC develops medical devices, coatings, 3D tissue engineering scaffolds, and drug delivery systems using proprietary electrospinning technology with FDA-approved polymers. The company serves the medical, pharmaceutical, and research sectors by providing nanofibrous materials designed to encourage healing, treat diseases, and support in vitro research.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.